Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Endo Pharmaceuticals, which engages in the research, development, sale and marketing of branded and generic prescription pharmaceuticals, has announced that executive vice president and CFO, Charles Rowland, Jr, has resigned effective immediately, to pursue other interests.
Subscribe to our email newsletter
Endo Pharmaceuticals has engaged an executive search firm to assist in the search for a new CFO.
David Holveck, president and CEO of Endo Pharmaceuticals, said: “The board and I wish to express our gratitude to Charlie for his contributions and service and wish him well in his future endeavors.”